Xenograft models for normal and malignant stem cells.

Blood
Susumu GoyamaJames C Mulloy

Abstract

The model systems available for studying human hematopoiesis, malignant hematopoiesis, and hematopoietic stem cell (HSC) function in vivo have improved dramatically over the last decade, primarily due to improvements in xenograft mouse strains. Several recent reviews have focused on the historic development of immunodeficient mice over the last 2 decades, as well as their use in understanding human HSC and leukemia stem cell (LSC) biology and function in the context of a humanized mouse. However, in the intervening time since these reviews, a number of new mouse models, technical approaches, and scientific advances have been made. In this review, we update the reader on the newest and best models and approaches available for studying human malignant and normal HSCs in immunodeficient mice, including newly developed mice for use in chemotherapy testing and improved techniques for humanizing mice without laborious purification of HSC. We also review some relevant scientific findings from xenograft studies and highlight the continued limitations that confront researchers working with human HSC and LSC in vivo.

References

Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C M BaumB Peault
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·M BhatiaJ E Dick
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·D S PereiraJ E Dick
Nov 9, 2000·The Journal of Experimental Medicine·F N KaranuM Bhatia
Jan 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Christopher J HoganGordon Keller
Jul 26, 2002·Proceedings of the National Academy of Sciences of the United States of America·Guenahel H DanetDominique A Bonnet
Mar 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Barbara MurdochMickie Bhatia
Jul 10, 2004·Blood·Charlotte V CoxAllison Blair
Aug 25, 2004·Cancer Cell·Annapoorni RangarajanRobert A Weinberg
Sep 9, 2004·The Journal of Experimental Medicine·Jan Jacob SchuringaMalcolm A S Moore
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Leonard D ShultzRupert Handgretinger
May 24, 2005·Nature Medicine·Anders CastorSten Eirik W Jacobsen
Dec 13, 2005·Nature Medicine·Jennifer J TrowbridgeMickie Bhatia
Sep 26, 2006·Nature Medicine·Liqing JinJohn E Dick
Oct 24, 2006·Nature Medicine·Michael W MelkusJ Victor Garcia
Nov 2, 2006·Proceedings of the National Academy of Sciences of the United States of America·J A KennedyJ E Dick
Mar 24, 2007·Stem Cells·Christina Holmes, William L Stanford
Jun 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Naoki HosenIrving L Weissman
Nov 6, 2007·Nature Immunology·Katsuto TakenakaJayne S Danska

❮ Previous
Next ❯

Citations

Nov 8, 2015·Experimental Hematology·Eugenia Flores-FigueroaTeresa V Bowman
Sep 30, 2015·Pharmaceutical Research·Alexander L PerrymanJoel S Freundlich
Dec 15, 2015·Annals of the New York Academy of Sciences·Aditi VediElisa Laurenti
Jul 26, 2016·Frontiers in Oncology·Anilkumar GopalakrishnapillaiSonali P Barwe
Aug 27, 2016·Expert Opinion on Drug Discovery·Sanil BhatiaJulia Hauer
Feb 6, 2017·Blood·Daniel Thomas, Ravindra Majeti
Feb 6, 2017·Blood·Tessa L Holyoake, David Vetrie
Jun 14, 2017·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Luca Basso-RicciLuca Biasco
Jul 7, 2017·Stem Cells Translational Medicine·Hidekazu NishikiiShigeru Chiba
Nov 9, 2016·World Journal of Stem Cells·Maximilian StahlAmer M Zeidan
Nov 15, 2019·FEBS Letters·José Gabriel Barcia DuránShahin Rafii
Apr 24, 2020·ILAR Journal·Katrien DevolderThomas Douglas
May 8, 2020·Blood·Rachel E Rau
Apr 14, 2017·Frontiers in Immunology·Silvia Lopez-Lastra, James P Di Santo
Jun 24, 2017·Nature Reviews. Cancer·Michael W N DeiningerEric Solary
Oct 28, 2019·Nature Communications·Yasutaka HayashiToshio Kitamura
Aug 23, 2020·Nature Protocols·Chuan YanDavid M Langenau
Feb 7, 2020·Nature Communications·Carl SandénThoas Fioretos
Jan 1, 2020·International Journal of Molecular Sciences·Yoshie KametaniYutaka Tokuda
May 30, 2020·Nature Reviews. Genetics·Adam C WilkinsonHiromitsu Nakauchi
Dec 3, 2016·Nature·Jun WuJuan Carlos Izpisua Belmonte

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

© 2021 Meta ULC. All rights reserved